Alexandra Richardson, PhD, CLP April 2015

Transcription

1 Alexandra Richardson, PhD, CLP April 2015

2 Clayton Biotechnologies, Inc. is a for-profit company which facilitates the commercialization of medical discoveries made by the Clayton Foundation for Research and its supporting entities. The Clayton Foundation for Research is a nonprofit medical research organization in Houston, Texas established in 1933 by Benjamin Clayton. The two-fold mission of the Foundation is to: conduct medical research for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind, and transfer the resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for development into drugs or other products. 2

3 Medical Research at Leading Research Institutions U. of Geneva North Carolina State UCSD Salk UT-Austin UT-Southwestern MD Anderson UTHSC-San Antonio Baylor College of Medicine UT-Medical Branch 3 Medical research for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind

4 Medical Research to Develop Cures Cancer CNS & Ophthalmology Metabolic Diseases Immunotoxins for targeted cancer therapy Avicin to treat Mantle cell Lymphoma Monoclonal antibodies targeting angiogenesis Stem Cell Therapy for Parkinson s Disease Modulation of brain stress in neurological diseases Urocortin peptides for diabetes GLP-1 combination therapy Engineered proteases Next generation anti-mitotic drugs Fc engineered aglycosylated antibodies Genetic disease models for neurological diseases Gene therapy and peptide therapeutics for AMD Molecular switches in glucose control Serum oxysterols as biomarkers of disease 4

5 Medical Research to Develop Cures Infectious Diseases Autoimmune & Inflammation Cardiology Endometriosis Vaccines for Dengue and Chinkungunya Engineered proteases Urocortin peptides and gene therapy for congestive heart failure Small molecules targeting SRC Vaccines and diagnostics for Ehrlichioses Fc engineering of aglycosylated antibodies OCT-TPL diagnostics of human vascular plaques OCT Image Guided Laser knife for diagnosis and treatment 5

6 Leaders in Innovation and Technology Stem Cell Therapy Examples Gene Therapy Neuropeptides Protein Engineering, Antibodies and Immunotoxins 6

7 Transforming Research Into Products Mission Two: To transfer the resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for development into drugs or other products. Collaborations Spin-out companies Licensing 7

8 Portfolio of Start-up Companies 8

9 Some of Our Other Licensees 9

10 Marketed Products Exparel DepoDur Morphine liposome injectable suspension Post-operative pain Depocyt Cytarabine liposomes injectable suspension Lymphomatous and solid tumor meningitis Attrius Retcam AccuPlex 4 SCA6 Diagnostic tests FIA 10 bupivacaine liposome injectable suspension Pain Cardiac PET Imaging Medical imaging systems for private practices Neonatal and pediatric imaging system Wide-field digital imaging system for the hospital and clinic Ehrlichoisis canine Assay for canine vector borne diseases Ataxia diagnostic Assay for Spinocerebellar ataxia type 6 (SCA6) Functional Intracellular analysis Assay for intracellular function of essential micronutrients

11 Clinical Pipeline Candidate compound Indication Development Stage Partner Lenti-D Childhood ALD Pre-clinical Phase I Phase II/III LentiGlobin Betathalassemia Pre-clinical Phase I/II LentiGlobin Sickle cell anemia Pre-clinical Phase I Retinostat AMD Pre-clinical Phase I Urocortin Congestive Heart Failure Pre-clinical Phase I Phase II Available to Partner VC-01 Type I Diabetes Pre-clinical Phase I 11 α-tea Breast cancer Pre-clinical Phase I A Cancer Research Hospital

12 Advanced Pre-clinical Pipeline Candidate compound 12 Indication Development Stage Encorstat Corneal graft rejection Pre-clinical Avicin Mantle Cell Lymphoma Pre-clinical Dengue tetra vaccine Dengue Fever IND package VEGF-rGel Solid Tumors IND package VEGF-rGel AMD Advanced pre-clinical Partner IND IND Available to Partner Available to Partner

13 Collaboration and Licensing Opportunities Urocortins and analogues for Diabetes GLP-1 agonist combination therapies for Diabetes Alk4-Fc, a Cripto antagonist for Cancer Granzyme B - a potent payload for antibody drug conjugates (ADC) YESS - engineering of proteases Fc engineered antibodies with specific effector function 13 Filaggrin to treat dermatological disorders TEAD gene and peptide therapies for ocular neovascular disease CRFR1 antagonists - therapeutic for early onset AD Stem cell therapy program for Parkinson's Disease Vaccines and Diagnostics for Ehrlichioses OCT guided laser knife for surgery in small spaces

14 Conducting and funding research Transferring research into products One Riverway, Suite 1520 Houston, Texas